Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Monte Caldera is a data-driven scientific firm that offers consulting and molecular-level simulation services to a wide array of industries.
Gisens Biotech provides bioelectronics and nanotechnology services.
Microgenesis offers a new fertility test and treatment that restores the fertility potential of women everywhere.
Nanogrow Biotech is a manufacturer of nano antibiotics with the goal of developing novel applications in the pharmaceutical industry.
Insecticides inspired by arachnid venom
We offer an on-site organic waste management service which uses our insect-based biotechnolgy platform to create high value-added products.
Invitrall develops advanced diseases in vitro models that represent human genetic diversity that provides innovative solutions.
Organic coatings that protect produce from spoilage and decay.
MIGMA uses Artificial Intelligence to accelerate the discovery of new synergistic combinations of antioxidants.
Next-gen gut health delivery using bacterial vesicles for precise, effective, and cost-efficient supplement delivery.
Cell rejuvenation with small molecules — no gene editing required. Starting with cancer, extending to longevity.
UpDairy is a food tech startup company that develops alternative dairy proteins through precision fermentation.
Bioeutectics is revolutionising the solvent industry, turning it into one that is natural and biodegradable.
Aquit develops preventive treatments for infections in fish that replace antibiotics, improve survival rates, and boost natural immunity.
Food4You is a biotech platform that offers natural ingredients for plant-based food.
Transforming ingredients into high-performance bio-nanoparticles with over 15% enhanced bioavailability to redefine nutrition and longevity.
Cryosmetics designs products to take care of the skin with the aim of promoting the skin and its microbiome's health.
Bioplastix aims to produce biomaterials with outstanding properties, derived from renewable sources at competitive prices.
Syocin Biotech is focused on improving world fruits and vegetable availability through the development of highly-precise biobactericides.
CyanoMin harnesses cyanobacteria to make carbon-negative minerals without mining, reducing the net carbon footprint of the products.
Pioneering novel antibody-based cancer therapies informed by large-scale patient-derived biology.
Oral vaccines for farmed animals. Vaccination simple and hassle free.
BioPlaster Research seeks the development of science and technology for the care of the environment and the proliferation of nanotechnology.
Fecundis develops technologies that enhance sperm functionality, resulting in the generation of more and better embryos.
GRID EXPONENTIAL has invested in 51 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
GRID EXPONENTIAL's top investment sectors include Biotechnology, Health Care, Food and Beverage, Health Diagnostics, Life Science. The firm invests across 37 different industry categories.
Among tracked funding rounds, OncoPrecision received $4.5M in a Seed round. GRID EXPONENTIAL's total known invested capital is $34.4M.
GRID EXPONENTIAL's average investment size is $783K across its portfolio of 51 companies.
Recent GRID EXPONENTIAL portfolio additions include Monte Caldera, Gisens Biotech, Microgenesis, Nanogrow Biotech, Arakion. These companies were founded in 2020 or later.